Reduction of C-peptide levels starts sometime during the prediabetes stage and keeps going down with the progress of the disease.
With the new ultrasensitive C-peptide assays, remaining b-cell function extends for years after loss of pancreas function and in some cases extends to 40 years after diagnosis